首页> 外国专利> USE OF AGENTS THAT PREVENT THE GENERATION OF AMYLOID-LIKE PROTEINS AND/OR DRUSEN, AND/OR USE OF AGENTS THAT PROMOTE SEQUESTRATION AND/OR DEGRADATION OF, AND/OR PREVENT THE NEUROTOXIC EFFECTS OF SUCH PROTEINS IN THE TREATMENT OF MACULAR DEGENERATION

USE OF AGENTS THAT PREVENT THE GENERATION OF AMYLOID-LIKE PROTEINS AND/OR DRUSEN, AND/OR USE OF AGENTS THAT PROMOTE SEQUESTRATION AND/OR DEGRADATION OF, AND/OR PREVENT THE NEUROTOXIC EFFECTS OF SUCH PROTEINS IN THE TREATMENT OF MACULAR DEGENERATION

机译：防止淀粉样蛋白和/或酒糟生成的试剂的使用，和/或促进此类蛋白的分离和/或防止此类蛋白的神经氧化作用的蛋白的使用，在治疗黄斑变性中

页面导航

摘要
著录项
相似文献

摘要

The present invention provides compositions and methods for treating age-related macular degeneration (AMD). More specifically, the methods of the invention target amyloid proteins and drusen that tend to accumulate in the eyes of those patients suffering from AMD. AMD is treated in the methods of the invention by providing agents that sequester and/or degrade such amyloid deposits and/or drusen such that a patient's vision is improved or restored.

机译：本发明提供了用于治疗年龄相关性黄斑变性（AMD）的组合物和方法。更具体地，本发明的方法靶向倾向于在那些患有AMD的患者的眼中积累的淀粉样蛋白和玻璃疣。在本发明的方法中，通过提供螯合和/或降解此类淀粉样蛋白沉积物和/或玻璃疣的试剂来治疗AMD，从而改善或恢复患者的视力。

著录项

公开/公告号US2009203614A1

专利类型
公开/公告日2009-08-13

原文格式PDF
申请/专利权人 NAJAM A. SHARIF;
展开▼

申请/专利号US20090425774
发明设计人 NAJAM A. SHARIF;
展开▼

申请日2009-04-17
分类号A61K38/17;A61P27/02;
国家 US
入库时间 2022-08-21 19:36:50

相似文献

专利
外文文献
中文文献